aqueous insulin preparation, parenteral pharmaceutical formulation, and process for enhancing the chemical stability of an insulin preparation.

摘要

Insulin preparations of superior chemical stability, comprising human insulin or an analogue or derivative thereof, glycerol and/or mannitol, and 5 to 100 mM of the halogenide are disclosed.